BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31788997)

  • 1. Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer.
    Kong TW; Son JH; Paek J; Chang SJ; Ryu HS
    J Gynecol Oncol; 2020 Jan; 31(1):e7. PubMed ID: 31788997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of recurrence and survival after abdominal versus laparoscopic/robotic radical hysterectomy in patients with early cervical cancer.
    Kong TW; Chang SJ; Piao X; Paek J; Lee Y; Lee EJ; Chun M; Ryu HS
    J Obstet Gynaecol Res; 2016 Jan; 42(1):77-86. PubMed ID: 26554751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparotomic radical hysterectomy versus minimally invasive radical hysterectomy using vaginal colpotomy for the management of stage IB1 to IIA2 cervical cancer: Survival outcomes.
    Yang EJ; Kim NR; Lee AJ; Shim SH; Lee SJ
    Medicine (Baltimore); 2022 Feb; 101(8):e28911. PubMed ID: 35212297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
    Nica A; Kim SR; Gien LT; Covens A; Bernardini MQ; Bouchard-Fortier G; Kupets R; May T; Vicus D; Laframboise S; Hogen L; Cusimano MC; Ferguson SE
    Int J Gynecol Cancer; 2020 Dec; 30(12):1864-1870. PubMed ID: 33037109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
    Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1269-1277. PubMed ID: 32788262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
    Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
    Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Use of a Uterine Manipulator or Intracorporeal Colpotomy Confer an Inferior Prognosis in Minimally Invasive Surgery-Treated Early-stage Cervical Cancer?
    Wang R; Hu Y; Xia H; Zhu X
    J Minim Invasive Gynecol; 2023 Feb; 30(2):156-163. PubMed ID: 36410659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Maneuver to Avoid Tumor Spillage during Laparoscopic Radical Hysterectomy: Vaginal Cuff Closure.
    Lago V; Tiermes M; Padilla-Iserte P; Matute L; Gurrea M; Domingo S
    J Minim Invasive Gynecol; 2021 Feb; 28(2):174-175. PubMed ID: 32540498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].
    Zhou D; Li YD; Ling KJ; Wang RW; Wang YZ; Tang S; Liang ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):49-59. PubMed ID: 36720615
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival after minimally invasive radical hysterectomy with protective colpotomy for early-stage cervical cancer: A systematic review and meta-analysis.
    Song YL; Li RZ; Feng BJ; Lu YH; Wang LF; Wang ZY; Pei KG; Sun LF; Li R
    Eur J Surg Oncol; 2024 Apr; 50(4):108240. PubMed ID: 38457858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
    Ramirez PT; Frumovitz M; Pareja R; Lopez A; Vieira M; Ribeiro R; Buda A; Yan X; Shuzhong Y; Chetty N; Isla D; Tamura M; Zhu T; Robledo KP; Gebski V; Asher R; Behan V; Nicklin JL; Coleman RL; Obermair A
    N Engl J Med; 2018 Nov; 379(20):1895-1904. PubMed ID: 30380365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of diffusion-weighted and dynamic contrast-enhanced MR in predicting parametrial invasion in cervical stromal ring focally disrupted stage IB-IIA cervical cancers.
    Song J; Hu Q; Ma Z; Zhang J; Chen T
    Abdom Radiol (NY); 2019 Sep; 44(9):3166-3174. PubMed ID: 31377834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy.
    Kong TW; Son JH; Paek J; Chang SJ; Ryu HS
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():94-99. PubMed ID: 32590168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoendoscopic Single-site Radical Hysterectomy with Vaginal Closure and without Uterine Manipulator for FIGO IB1 Cervical Cancer.
    Chen S; Zheng Y; Tong L; Zhao X; Chen L; Wang Y
    J Minim Invasive Gynecol; 2020; 27(7):1471-1472. PubMed ID: 31926301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Kim SI; Cho JH; Seol A; Kim YI; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS
    Gynecol Oncol; 2019 Apr; 153(1):3-12. PubMed ID: 30642625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
    Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).
    Kong TW; Kim J; Son JH; Lee AJ; Yang EJ; Shim SH; Kim NK; Kim Y; Suh DH; Hwang DW; Park SJ; Kim HS; Lee YY; Yoo JG; Lee SJ; Chang SJ
    Gynecol Oncol; 2023 Sep; 176():122-129. PubMed ID: 37515926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.